Canada markets open in 7 hours 30 minutes

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
34.58+0.92 (+2.73%)
At close: 04:00PM EDT
34.58 0.00 (0.00%)
After hours: 04:27PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.96B
Enterprise Value 1.26B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)71.75
Price/Book (mrq)2.42
Enterprise Value/Revenue 46.91
Enterprise Value/EBITDA -3.27

Trading Information

Stock Price History

Beta (5Y Monthly) 0.86
52-Week Change 331.79%
S&P500 52-Week Change 321.33%
52 Week High 335.50
52 Week Low 319.80
50-Day Moving Average 330.43
200-Day Moving Average 325.65

Share Statistics

Avg Vol (3 month) 3763.81k
Avg Vol (10 day) 3742.2k
Shares Outstanding 556.77M
Implied Shares Outstanding 656.77M
Float 847.69M
% Held by Insiders 11.46%
% Held by Institutions 1107.45%
Shares Short (Apr 15, 2024) 46.65M
Short Ratio (Apr 15, 2024) 410.41
Short % of Float (Apr 15, 2024) 411.98%
Short % of Shares Outstanding (Apr 15, 2024) 411.84%
Shares Short (prior month Mar 15, 2024) 46.85M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,496.23%

Management Effectiveness

Return on Assets (ttm)-22.49%
Return on Equity (ttm)-36.83%

Income Statement

Revenue (ttm)26.82M
Revenue Per Share (ttm)0.48
Quarterly Revenue Growth (yoy)64.80%
Gross Profit (ttm)N/A
EBITDA -384.86M
Net Income Avi to Common (ttm)-352.09M
Diluted EPS (ttm)-6.33
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)776.93M
Total Cash Per Share (mrq)13.83
Total Debt (mrq)72M
Total Debt/Equity (mrq)8.88%
Current Ratio (mrq)12.27
Book Value Per Share (mrq)14.50

Cash Flow Statement

Operating Cash Flow (ttm)-296.06M
Levered Free Cash Flow (ttm)-215.06M